The Priority Review

Tag

Schizophrenia

1 story

  1. Clinical trials

    Intra-Cellular Therapies, Inc. posts results of Lumateperone schizophrenia relapse study

    The Phase 3 study enrolled 592 participants and was completed with primary completion on July 25, 2024. Results were first posted on ClinicalTrials.gov on October 5, 2026.